On the 24th of August 2001, a group of business and licensing executives united in Basel and founded the Swiss Pharma Licensing Group. The first Board defined objectives, recruited members and set up the foundation for today’s association.
|Swiss HLG, member of the European Pharma Licensing Council (EPLC), invites you to join the International Pharma Licensing Symposium in Paris |
Without question we live in interesting times, the 15th IPLS has been
designed to explore some of the more disruptive influences and opportunities in the life science industry today.
Two days of informative presentations from industry leading speakers, peer to peer networking, one-to-one meeting opportunities and continuous personal development, all in the world’s most popular and dynamic city, Paris.
Conference Programme Includes:
Contemporary Trends in Pharma Business Development
Evolution of Business Development Teams
The Continuum of Ageing & Age-Related Diseases
Ageing Opportunities in Pharmaceuticals
New Therapeutic Advances
And much more, including 7 hours of dedicated one-to-one partnering
Full Programme & Event Website
REGISTER ONLINE NOW
|XV International Pharma Licensing Symposium|
Pullman Hotel Paris Centre – Bercy
Wednesday 18th to Friday 20th September 2019
Who Should Attend? Business Development Professionals, Managing
Directors, General Managers, Business Owners, Investors, Advisors,
Financial, Marketing& Regulatory Executives
REGISTER ONLINE NOW
Swiss HLG would like to inform you of an excellent workshop organized by our partner the Swiss Biotech Association with top speakers.
This first in a series of Swiss Biotech Insight Events will address major clinical trial strategy
Clinical trial strategy: Fine-tuning the risk-reward profile
Thursday, September 19, 2019, 13:00 – 18:30
Paternot room at Agora Cancer Research Centre, CHUV, Rue du Bugnon 25A, Lausanne
The joint summer conference between the Italian and Swiss Healthcare Licensing Groups took place on the 6th – 7th June in Milan. Over 80 attendees enjoyed the cutting-edge conference on various topics including, The current Italian and Swiss pharmaceutical markets evolution, Partnering in the field of advanced therapies, analysis of 2018 and beginning of 2019 BD&L deals with an interesting discussion about the trends. The artificial intelligence and its impact on BD&L, Business intelligence as a tool to evaluate new BD&L opportunities, Health technology and its impact on the value chain and Trends in the orphan drugs regulations and pricing and pricing of breakthrough therapies in a challenging healthcare system.Read More…